Group CEO and Managing Director

TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX

Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX

TLX250-CDx (Zircaix®) Included in Leading International Guidelines for Renal Imaging

Global Clinical Lead (Clinical Scientist)

Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company focused on precision medicine for cancer and rare diseases. The Global Clinical Lead will oversee the clinical development of novel imaging agents, ensuring alignment with scientific and commercial objectives while collaborating with cross-functional teams to design and execute clinical studies.

Sign up with Google

Sign in with Google